These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31059738)

  • 1. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma?
    Nesteruk K; Spaander MCW; Leeuwenburgh I; Peppelenbosch MP; Fuhler GM
    Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188291. PubMed ID: 31059738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.
    Leeuwenburgh I; Scholten P; Caljé TJ; Vaessen RJ; Tilanus HW; Hansen BE; Kuipers EJ
    Dig Dis Sci; 2013 Jan; 58(1):244-52. PubMed ID: 23179142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal adenocarcinoma in a patient with surgically treated achalasia.
    Goodman P; Scott LD; Verani RR; Berggreen CC
    Dig Dis Sci; 1990 Dec; 35(12):1549-52. PubMed ID: 2253539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's metaplasia and dysplasia in postmyotomy achalasia patients.
    Feczko PJ; Ma CK; Halpert RD; Batra SK
    Am J Gastroenterol; 1983 May; 78(5):265-8. PubMed ID: 6846301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal adenocarcinoma following Heller myotomy for achalasia.
    Gallez JF; Berger F; Moulinier B; Partensky C
    Endoscopy; 1987 Mar; 19(2):76-8. PubMed ID: 3569152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
    Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
    Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of Barrett's adenocarcinoma.
    Wijnhoven BP; Tilanus HW; Dinjens WN
    Ann Surg; 2001 Mar; 233(3):322-37. PubMed ID: 11224619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets for treatment of Barrett's esophagus.
    Feagins LA; Souza RF
    Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus and achalasia.
    Guo JP; Gilman PB; Thomas RM; Fisher RS; Parkman HP
    J Clin Gastroenterol; 2002 Apr; 34(4):439-43. PubMed ID: 11907357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature.
    Ellis FH; Gibb SP; Balogh K; Schwaber JR
    Dis Esophagus; 1997 Jan; 10(1):55-60. PubMed ID: 9079276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
    da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
    Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.
    Souza RF; Morales CP; Spechler SJ
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1087-100. PubMed ID: 11472311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Ekiz F; Ormeci N; Coban S; Karabulut HG; Aktas B; Tukun A; Tuncali T; Yüksel O; Alkış N
    Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.